These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7517987)

  • 21. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
    Carlo-Stella C; Di Nicola M; Magni M; Longoni P; Milanesi M; Stucchi C; Cleris L; Formelli F; Gianni MA
    Cancer Res; 2002 Nov; 62(21):6152-7. PubMed ID: 12414641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
    Misaki M; Ueyama Y; Tsukamoto G; Matsumura T
    Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An increase in peripheral blood progenitor cells in primates by coadministration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Ikebuchi K; Wada Y; Okano A; Nakamiya T; Akiyama Y; Sawada T; Asano S; Nakahata T
    Transplantation; 1997 Nov; 64(10):1468-73. PubMed ID: 9392313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination effects between KW-2228 and antibiotics against systemic infections in normal and neutropenic mice].
    Sato K; Yoneyama H; Yoshino T
    Jpn J Antibiot; 1992 Jan; 45(1):91-7. PubMed ID: 1379652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report].
    Yoshida M; Yoshikawa K; Maezawa H; Shindou N; Sakamoto M; Nakazawa Y; Shiba K; Saito A; Sakai O
    Kansenshogaku Zasshi; 1993 Aug; 67(8):767-71. PubMed ID: 7691973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
    Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
    Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of HS 6101 and rhG-CSF on Hematopoiesis Recovery of ICR Mice Injured by Cyclophosphamide].
    Xiong GL; Shen X; Liu XL; Yang M; Dai CL; Liu XY; Xing S; Yu ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1716-20. PubMed ID: 26708899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of the prophylactic and therapeutic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by pseudomonas aeruginosa in neutropenic mice].
    Tanaka N; Kumamoto Y; Hirose T; Yokoo A
    Kansenshogaku Zasshi; 1989 Feb; 63(2):145-55. PubMed ID: 2473150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].
    Xu B; Tian F; Yu J; Song Y; Shi J; Zhang B; Zhang Y; Yuan Z; Wu Q; Zhang Q; Nan K; Sun Q; Li W; Hu J; Bi J; Meng C; Dai H; Jiang H; Yue S; Cao B; Sun Y; Wang S; Tong Z; Shen P; Wu G; Tang L; Deng Y; Jia L; Shen K; Zhuang W; Xie X; Wu Y; Chen L
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):23-7. PubMed ID: 26796802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vivo effects on human neutrophils by administration of rhG-CSF and clinical significance].
    Okabe M; Saiki I; Nakane K; Miyazaki T
    Rinsho Byori; 1992 Apr; 40(4):397-402. PubMed ID: 1375667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia.
    Teng RJ; Wu TJ; Sharma R; Garrison RD; Hudak ML
    J Formos Med Assoc; 2015 Feb; 114(2):174-9. PubMed ID: 25678180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential administration of interleukin-6 and granulocyte-colony stimulating factor in newborn rats: modulation of newborn granulopoiesis and thrombopoiesis.
    Cairo MS; Plunkett JM; Nguyen A; Clark S; van de Ven C
    Pediatr Res; 1991 Dec; 30(6):554-9. PubMed ID: 1725208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating donor mice with rhIL-11 and rhG-CSF promotes transplant-tolerance and preserves the effects of GVL after allogeneic bone marrow transplantation.
    Huang XJ; Zhao J; Zhao XY; Chang YJ
    Leuk Res; 2009 Jan; 33(1):123-8. PubMed ID: 18653235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
    Hansen PB; Johnsen HE; Ralfkiaer E; Jensen L; Gaarsdal E; Hansen NE
    Leuk Lymphoma; 1995 Nov; 19(5-6):453-60. PubMed ID: 8590846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) against various microbial infections in neutropenic mice.
    Matsumoto M; Matsubara S; Matsuno T; Ono M; Yokota T
    Microbiol Immunol; 1990; 34(9):765-73. PubMed ID: 1704477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.